While consumer tech chases the next smartwatch, NeuroMetrix is solving a $635B problem: chronic pain. They've quietly built the first wearable nerve stimulator that actually works, backed by $105M in funding and 79 employees who know their way around a nerve fiber.

"They didn't just invent automated nerve testing—they're building a new category of wearable pain therapy that Big Pharma can't copy."

Their tech stack reveals a pragmatic approach: Bootstrap for speed, HubSpot for B2B healthcare relationships, and jQuery (yes, still) because stability matters more than bleeding-edge frameworks when you're managing medical devices. The 2,631 monthly visits are low because they don't need mass-market traffic—they need the right patients and providers finding them.

• First wearable nerve stimulator for chronic pain management (not just TENS 2.0)
• Automated nerve testing concept—think of it as the EKG for your peripheral nervous system
• Clinical partnerships over consumer marketing (VP Brandi Damkier leads this)
• Revenue growing despite minimal digital footprint—this is enterprise healthcare sales at work